ENvue Medical, Inc.

ENvue Medical, Inc. introduced 'Ask Oscar™', a new AI-powered training platform designed to overcome medical technology adoption barriers by enabling independent clinician training. This launch signifies the company's strategic transformation from a medical device maker to an AI platform company, with Ask Oscar expected to be commercially available within months, creating a new recurring revenue stream. The platform is also designed to integrate with ENvue's robotic feeding tube solution, ENvue Drive, and builds on the success of its existing navigation platform.

ENvue Medical announced that a major U.S. academic health network has expanded its use of the ENvue Navigation Platform into its American Burn Association-verified burn intensive care unit. This marks the second deployment within the same health system, demonstrating increased institutional trust and clinical versatility of the platform. The ENvue Navigation Platform, which is FDA 510(k) cleared for adult use, is now deployed across 40 hospitals in the U.S., addressing the demand for modernizing feeding tube placement in complex care environments.

ENvue Medical announced an independent, peer-reviewed study published in Critical Care Nurse, validating its ENvue™ Navigation Platform. The study at Inova Health System demonstrated significant improvements in patient safety and operating cost reductions, including over $1.5 million in avoided hospital costs and a 67% reduction in ventilator-associated pneumonia (VAP) cases in the first year. The findings are expected to accelerate clinical adoption and support commercialization efforts for the real-time guided feeding tube placement technology.

ENvue Medical reported a significant decline in its first-quarter 2026 financial results, with revenues decreasing by 36% to $653,000 and the company incurring a gross loss of $55,000. The net loss widened to $3.82 million, and the net loss available to common stockholders dramatically increased to $22.62 million due to preferred stock dividends and deemed dividends. The company also reported increased cash usage in operations and raised substantial doubt about its ability to continue as a going concern.

ENvue Medical, Inc. announced a three-year contract renewal with a leading integrated nonprofit health system operating 12 hospitals across Virginia and North Carolina. The ENvue™ Navigation Platform has been adopted as the standardized protocol for bedside enteral feeding tube placement across the entire network, signifying significant commercial validation. This standardization embeds the technology into clinical workflow, driving consistent utilization and extending the relationship through 2028. The company aims to replicate this model across other health systems.

ENvue Medical, Inc. announced that the USPTO has issued a Notice of Allowance for U.S. Patent Application No. 17/025,969. This patent covers a novel drug delivery system utilizing the Company's proprietary surface acoustic wave (SAW) technology to enhance transdermal delivery of cannabinoid-based therapeutics. The allowance provides broad intellectual property protection and is expected to expand ENvue's platform into a new therapeutic category, positioning the company favorably in the growing cannabinoid market.

ENvue Medical, Inc. announced a three-year purchasing agreement renewal with the Group Purchasing Organization (GPO) for one of the largest non-profit health systems in the United States. This renewal ensures that over 90 hospitals across 17 states within the network can access the ENvue Navigation Platform through established contracting pathways, eliminating the need for individual procurement processes. The agreement extends through 2028, providing a durable commercial foundation and reflecting confidence in ENvue's platform.

ENvue Medical issued a corporate update, highlighting 2025 as a transformative year that saw the company become a commercially active medtech business trading on Nasdaq. The company now operates with two proprietary technology platforms: ENvue Navigation and Acoustic Therapeutic. The ENvue Navigation Platform is commercially deployed in 39 U.S. hospitals, generating recurring revenue and addressing critical challenges in feeding tube placement.

ENvue Medical, Inc. (FEED) has filed its annual report on Form 10-K for the fiscal year ended December 31, 2025. The company confirmed its status as a non-accelerated filer and a smaller reporting company. Additionally, the filing indicated that ENvue Medical has complied with all required Section 13 or 15(d) reports during the preceding 12 months and has electronically submitted all Interactive Data Files.